CA2148255A1 - Preparation pour le traitement et particulierement la prevention des troubles du tube digestif - Google Patents

Preparation pour le traitement et particulierement la prevention des troubles du tube digestif

Info

Publication number
CA2148255A1
CA2148255A1 CA002148255A CA2148255A CA2148255A1 CA 2148255 A1 CA2148255 A1 CA 2148255A1 CA 002148255 A CA002148255 A CA 002148255A CA 2148255 A CA2148255 A CA 2148255A CA 2148255 A1 CA2148255 A1 CA 2148255A1
Authority
CA
Canada
Prior art keywords
preparation according
permeabilizer
preparation
diseases
indication
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002148255A
Other languages
English (en)
Inventor
Rainer Denecke
Irmingard Gebert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4307352A external-priority patent/DE4307352A1/de
Application filed by Individual filed Critical Individual
Publication of CA2148255A1 publication Critical patent/CA2148255A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Neurosurgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002148255A 1992-10-29 1993-10-22 Preparation pour le traitement et particulierement la prevention des troubles du tube digestif Abandoned CA2148255A1 (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DE4236469 1992-10-29
DEP4236469.8 1992-10-29
DE4304640 1993-02-16
DEP4304640.1 1993-02-16
DEP4307352.2 1993-03-09
DE4307352A DE4307352A1 (de) 1992-10-29 1993-03-09 Präparat zur Therapie und insbesondere Prophylaxe von Erkrankungen des Verdauungstraktes

Publications (1)

Publication Number Publication Date
CA2148255A1 true CA2148255A1 (fr) 1994-05-11

Family

ID=27204393

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002148255A Abandoned CA2148255A1 (fr) 1992-10-29 1993-10-22 Preparation pour le traitement et particulierement la prevention des troubles du tube digestif

Country Status (5)

Country Link
EP (1) EP0666759A1 (fr)
JP (1) JPH08504401A (fr)
AU (1) AU5174593A (fr)
CA (1) CA2148255A1 (fr)
WO (1) WO1994009806A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4432262A1 (de) * 1994-01-13 1995-07-20 Denecke Rainer Dr Med Vet Präparatkombination zur Therapie und Prophylaxe von Erkrankungen des Verdauungstraktes
US5804549A (en) * 1996-01-05 1998-09-08 Ambi Inc. Compositions with activity against helicobacter

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2264558A1 (en) * 1974-03-20 1975-10-17 Niviere Pierre Polymixin-methyl tetracycline salt antibiotics - active against Gram positive and negative bacteria, viruses and protozoa
JPS60215633A (ja) * 1984-04-11 1985-10-29 Terumo Corp 腸管吸収性ウロキナ−ゼリポソ−ム組成物
DE68913189T2 (de) * 1988-06-22 1994-05-19 Applied Microbiology, Inc., Brooklyn, N.Y. Nisin-zusammensetzungen zur anwendung als erhöhte breit-spektrum-bakterizide.
US4980163A (en) * 1989-03-01 1990-12-25 Public Health Research Institute Of The City Of New York Novel bacteriocin compositions for use as enhanced broad range bactericides and methods of preventing and treating microbial infection
US5043176A (en) * 1990-06-13 1991-08-27 Haarmann & Reimer Corp. Synergistic antimicrobial compositions
AU665188B2 (en) * 1991-04-15 1995-12-21 Applied Microbiology, Inc Pharmaceutical compositions against gastric disorders
IL104364A (en) * 1992-01-17 1997-09-30 Applied Microbiology Pharmaceutical compositions containing bacteriocins

Also Published As

Publication number Publication date
AU5174593A (en) 1994-05-24
JPH08504401A (ja) 1996-05-14
WO1994009806A1 (fr) 1994-05-11
EP0666759A1 (fr) 1995-08-16

Similar Documents

Publication Publication Date Title
US8853269B2 (en) Composition and method for treating infections and promoting intestinal health
JP4463773B2 (ja) Ｈｅｌｉｃｏｂａｃｔｅｒ種による感染症の予防および治療用経口製剤
EP0589893B1 (fr) Utilisation d'un agent bactériocine antimicrobien pour la fabrication d'un médicament pour le traitement de troubles gastriques associées avec Helicobacter pylori.
KR101188746B1 (ko) 에스-알릴-엘-시스테인을 유효성분으로 포함하는 위장질환 예방 또는 치료용 조성물
US5804549A (en) Compositions with activity against helicobacter
ES2228057T3 (es) Oregano para el tratamiento de parasitos internos y protozoos.
KR100282166B1 (ko) 약학적 박테리오신 조성물
WO1997025055A9 (fr) Combinaison de nisine et de monolaurate de glycerol agissante contre helicobacter
SK287892A3 (en) Pharmaceutical agents for treating of stomach and intestine deffects
Gümüs et al. The effects of pomegranate on bacterial translocation in rats with obstructive jaundice.
CA2148255A1 (fr) Preparation pour le traitement et particulierement la prevention des troubles du tube digestif
CN116590200A (zh) 约氏乳杆菌及其在制备预防和/或改善急性胰腺炎的产品中的应用
US9895387B2 (en) Compositions for treating Helicobacter pylori infection
US20030095961A1 (en) Composition and method for treating disease by increasing activated alpha2 macroglobulin in the blood and extravascular tissue
KR100375342B1 (ko) 위장 질환 개선을 위한 천연 항균물질 조성물
KR101762798B1 (ko) 아교 추출물을 포함하는 살모넬라균에 대한 항균용 약학적 조성물
JP2004534792A (ja) ニトロフラントイン及びウワウルシを含む組成物
WO1997025032A2 (fr) Compositions a base de monoglycerides et leur utilisation contre helicobacter
US20080145409A1 (en) Composition for the treatment and prevention of peptic ulcer
KR20240128192A (ko) 항염증 펩타이드 pn5를 포함하는 염증성 질환의 예방 또는 치료용 조성물
KR20110098565A (ko) 일라프라졸, 항생물질 및/또는 유산균을 포함하는 위장질환을 예방 또는 치료하기 위한 경구용 약제 조성물
DE4432262A1 (de) Präparatkombination zur Therapie und Prophylaxe von Erkrankungen des Verdauungstraktes
US20060194746A1 (en) Method and composition to inhibit infections with Helicobacter pylori by intake of procyanidins from type B and C
DE4307352A1 (de) Präparat zur Therapie und insbesondere Prophylaxe von Erkrankungen des Verdauungstraktes
WO2008058993A2 (fr) Nouvelle utilisation de composés chimiques actifs connus en pharmacologie

Legal Events

Date Code Title Description
FZDE Discontinued